Canada · Delayed Price · Currency is CAD Satellos Bioscience Statistics
Total Valuation
TSX:MSCL has a market cap or net worth of CAD 265.84 million. The enterprise value is 178.02 million.
| Market Cap | 265.84M |
| Enterprise Value | 178.02M |
Important Dates
The next estimated earnings date is Friday, November 13, 2026.
| Earnings Date | Nov 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TSX:MSCL has 21.22 million shares outstanding. The number of shares has increased by 46.32% in one year.
| Current Share Class | 21.22M |
| Shares Outstanding | 21.22M |
| Shares Change (YoY) | +46.32% |
| Shares Change (QoQ) | +13.00% |
| Owned by Insiders (%) | 6.94% |
| Owned by Institutions (%) | 41.63% |
| Float | 18.02M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 3.12 |
| P/TBV Ratio | 3.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.22
| Current Ratio | 11.22 |
| Quick Ratio | 10.68 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -70.45% and return on invested capital (ROIC) is -45.57%.
| Return on Equity (ROE) | -70.45% |
| Return on Assets (ROA) | -41.89% |
| Return on Invested Capital (ROIC) | -45.57% |
| Return on Capital Employed (ROCE) | -59.79% |
| Weighted Average Cost of Capital (WACC) | 10.70% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -2.46M |
| Employee Count | 21 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, TSX:MSCL has paid 218,695 in taxes.
| Income Tax | 218,695 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.93% in the last 52 weeks. The beta is 1.17, so TSX:MSCL's price volatility has been higher than the market average.
| Beta (5Y) | 1.17 |
| 52-Week Price Change | +55.93% |
| 50-Day Moving Average | 12.82 |
| 200-Day Moving Average | 11.21 |
| Relative Strength Index (RSI) | 42.33 |
| Average Volume (20 Days) | 10,744 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -13.46M |
| Operating Income | -50.87M |
| Pretax Income | -48.93M |
| Net Income | -49.15M |
| EBITDA | -50.86M |
| EBIT | -50.87M |
| Earnings Per Share (EPS) | -2.83 |
Balance Sheet
The company has 87.82 million in cash and no debt, with a net cash position of 87.82 million or 4.14 per share.
| Cash & Cash Equivalents | 87.82M |
| Total Debt | n/a |
| Net Cash | 87.82M |
| Net Cash Per Share | 4.14 |
| Equity (Book Value) | 85.08M |
| Book Value Per Share | 4.08 |
| Working Capital | 85.07M |
Cash Flow
In the last 12 months, operating cash flow was -41.18 million and capital expenditures -9,941, giving a free cash flow of -41.19 million.
| Operating Cash Flow | -41.18M |
| Capital Expenditures | -9,941 |
| Depreciation & Amortization | 6,895 |
| Net Borrowing | n/a |
| Free Cash Flow | -41.19M |
| FCF Per Share | -1.94 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSX:MSCL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -46.32% |
| Shareholder Yield | -46.32% |
| Earnings Yield | -18.49% |
| FCF Yield | -15.50% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for TSX:MSCL is 17.67, which is 41.93% higher than the current price. The consensus rating is "Buy".
| Price Target | 17.67 |
| Price Target Difference | 41.93% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on January 30, 2026. It was a reverse split with a ratio of 0.0833333.
| Last Split Date | Jan 30, 2026 |
| Split Type | Reverse |
| Split Ratio | 0.0833333 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |